Anders Hay-Schmidt

Anders Hay-Schmidt

Auto-generated profile, based on publicly available information

Anders Hay-Schmidt

Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZRZindy Raida
Zindy Raida
CHChristian Ansgar Hundahl
Christian Ansgar Hundahl
JNJens R. Nyengaard
Jens R. Nyengaard
AHAnders Hay-Schmidt
Anders Hay-Schmidt
Stroke is a major cause of death and severe disability, but effective treatments are limited. Neuroglobin, a neuronal heme-globin, has been advocated as a novel pharmacological target in combating stroke and neurodegenerative disorders based on cytoprotective properties. Using thoroughly validated antibodies and oligos, we give a detailed brain anatomical characterization of transgenic mice over expressing Neuroglobin. Moreover, using permanent middle artery occlusion the effect of elevated levels of Neuroglobin on ischemic damage was studied. Lastly, the impact of mouse strain genetic background on ischemic damage was investigated. A four to five fold increase in Neuroglobin mRNA and protein expression was seen in the brain of transgenic mice. A β-actin promoter was used to drive Neuroglobin over expression, but immunohistochemistry and in situ hybridization showed over expression to be confined to primarily the cortex, hippocampus, cerebellum, and only in neurons. The level and expression pattern of endogenous Neuroglobin was unaffected by insertion of the over expressing Ngb transgene. Neuroglobin over expression resulted in a significant reduction in infarct volume 24 hours after ischemia. Immunohistochemistry showed no selective sparing of Neuroglobin expressing cells in the ischemic core or penumbra. A significant difference in infarct volume was found between mice of the same strain, but from different colonies. In contrast to some previous reports, Neuroglobin over expression is not global but confined to a few well-defined brain regions, and only in neurons. This study confirms previous reports showing a correlation between reduced infarct volume and elevated Neuroglobin levels, but underlines the need to study the likely contribution from compensatory mechanisms to the phenotype following a genetic perturbation. We also stress, that care should be taken when comparing results where different mouse strains and colonies have been used due to large genetic background contribution to the observed phenotype.

20 August 2012 in Experimental & Translational Stroke Medicine
Verified
Journal Article
Open access
PDF file
ZRZindy Raida
Zindy Raida
CHChristian Ansgar Hundahl
Christian Ansgar Hundahl
JKJesper Kelsen
Jesper Kelsen
JNJens Randel Nyengaard
Jens Randel Nyengaard
AHAnders Hay-Schmidt
Anders Hay-Schmidt
Neuroglobin is considered to be a novel important pharmacological target in combating stroke and neurodegenerative disorders, although the mechanism by which this protection is accomplished remains an enigma. We hypothesized that if neuroglobin is directly involved in neuroprotection, then permanent cerebral ischemia would lead to larger infarct volumes in neuroglobin-null mice than in wild-type mice.


13 July 2022 in Journal of Neuroscience Research
Verified
Journal Article
Open access
CGCasper R. Gøtzsche
Casper R. Gøtzsche
DWDavid P. D. Woldbye
David P. D. Woldbye
CHChristian Ansgar Hundahl
Christian Ansgar Hundahl
AHAnders Hay‐Schmidt
Anders Hay‐Schmidt
Neuroglobin (Ngb) is found in the neurones of several different brain areas and is known to bind oxygen and other gaseous molecules and reactive oxygen species (ROS) in vitro, but it does not seem to act as a respiratory molecule for neurones. Using male and female Ngb‐knockout (KO) mice, we addressed the role of Ngb in neuronal brain activity using behavioral tests but found no differences in general behaviors, memory processes, and anxiety−/depression‐like behaviors. Oxidative stress and ROS play key roles in epileptogenesis, and oxidative injury produced by an excessive production of free radicals is involved in the initiation and progression of epilepsy. The ROS binding properties led us to hypothesize that lack of Ngb could affect central coping with excitatory stimuli. We consequently explored whether exposure to the excitatory molecule kainate (KA) would increase severity of seizures in mice lacking Ngb. We found that the duration and severity of seizures were increased, while the latency time to develop seizures was shortened in Ngb‐KO compared to wildtype adult female mice. Consistently, c‐fos expression after KA was significantly increased in Ngb‐KO mice in the amygdala and piriform cortex, regions rich in Ngb and known to be centrally involved in seizure generation. Moreover, the measured c‐fos expression levels were correlated with seizure susceptibility. With these new findings combined with previous studies we propose that Ngb could constitute an intrinsic defense mechanism against neuronal hyperexcitability and oxidative stress by buffering of ROS in amygdala and other Ngb‐containing brain regions.

8 August 2013 in Experimental & Translational Stroke Medicine
Verified
Journal Article
Open access
PDF file
ZRZindy Raida
Zindy Raida
CHChristian Ansgar Hundahl
Christian Ansgar Hundahl
JKJesper Kelsen
Jesper Kelsen
JNJens Randel Nyengaard
Jens Randel Nyengaard
AHAnders Hay-Schmidt
Anders Hay-Schmidt
Since the publication of our article it has come to our attention that our Discussion inadvertently includes some sentences taken from the following articles by DeVries et al. and Bouet et al. without appropriate citation, using quotation marks:

7 April 2024 in Zoomorphology
Verified
Journal Article
Open access
PDF file
AHAnders Hay-Schmidt
Anders Hay-Schmidt
JHJens T. Hoeg
Jens T. Hoeg